Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
Biotechnology Equipment

PUBLISHER: Grand View Research | PRODUCT CODE: 1363222

Cover Image

PUBLISHER: Grand View Research | PRODUCT CODE: 1363222

Clinical Microbiology Market Size, Share & Trends Analysis Report By Product, By Disease (Bloodstream, Respiratory, Gastrointestinal, Periodontal, STD, UTI), By Region, And Segment Forecasts, 2023 - 2030

PUBLISHED:
PAGES: 94 Pages
DELIVERY TIME: 2-10 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
Unprintable PDF (Single User License)
USD 5950
Printable PDF (5-User License)
USD 6950
Printable PDF (Enterprise License)
USD 8950

Add to Cart

Description

Table of Contents

List of Tables

Clinical Microbiology Market Growth & Trends:

The global clinical microbiology market size is expected to reach USD 7.6 billion by 2030, registering a CAGR of 7.1% during the forecast period, according to a new report by Grand View Research, Inc.. It is projected to expand at a CAGR of 6.7% over the forecast period. Clinical microbiology depends on technical and skilled workforce to process and interpret results of clinical specimens. Clinical staff have been complaining about poor Turnaround Time (TAT) of tests. However, with technological advancements, a number of laboratory instruments and equipment are being replaced with automated devices to minimize human error and dependency on skilled workforce.

In addition, automation has benefits such as reduced TAT and use of labor and lab space, thereby reducing overall cost associated with these tests. Manufacturers are focusing on introduction of automatic specimen processing, plate reading, and organism identification. GE Healthcare, PerkinElmer, and Thermo Fisher are some of the key players offering automated systems in the diagnostics industry.

Rising cases of hospital-acquired infections (HAI) is also fueling demand for clinical microbiology for diagnosis and monitoring. As high-income countries are stepping up their pursuit of countering hospital-acquired infections, middle- and low-income countries are recognizing the threat. Introduction of automated systems and innovative designs is expected to intensify market competition and change market dynamics over the forecast period.

The World Health Organization (WHO) is particularly active in countries such as Ethiopia, Burkina Faso, Nigeria, Algeria, and Senegal, where occurrence of HAIs ranged between 2.5% and 14.8%. This has led to increased demand for HAI diagnostics in these countries. Countries such as India, Sri Lanka, Pakistan, and Bhutan are also actively participating in HAI awareness programs. India and China are projected to be the main countries driving demand for HAI diagnostics instruments and tests in future.

Clinical Microbiology Market Report Highlights:

  • The molecular diagnostic instruments segment is expected to exhibit the fastest growth rate over the forecast period. This growth can be attributed to the increasing significance of molecular diagnosis in the early detection of cancer and infectious diseases.
  • Reagents captured the largest revenue share in 2022 owing to repeat purchase of reagents
  • In 2022, North America dominated the global market. Continuous research on infectious disease treatment and subsequent grants from government healthcare agencies are contributing to development of a strong ecosystem in the region
  • Asia Pacific is expected to emerge as the fastest growing region during the forecast period owing to rising geriatric population in India, China, and Japan. This has resulted in high prevalence of re-emerging infectious diseases such as tuberculosis, cholera, and typhoid
Show more
Product Code: GVR-1-68038-142-9

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Product
    • 1.1.2. Disease
    • 1.1.3. Regional scope
    • 1.1.4. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product outlook
    • 2.2.2. Disease outlook
    • 2.2.3. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Clinical Microbiology Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Market Dynamics
    • 3.3.1. Market driver analysis
    • 3.3.2. Market restraint analysis
  • 3.4. Clinical Microbiology Market Analysis Tools
    • 3.4.1. Industry Analysis - Porter's
      • 3.4.1.1. Supplier power
      • 3.4.1.2. Buyer power
      • 3.4.1.3. Substitution threat
      • 3.4.1.4. Threat of new entrant
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Technological landscape
      • 3.4.2.3. Economic landscape

Chapter 4. Clinical Microbiology : Product Estimates & Trend Analysis

  • 4.1. Clinical Microbiology Market: Key Takeaways
  • 4.2. Clinical Microbiology Market: Movement & Market Share Analysis, 2022 & 2030
  • 4.3. Laboratory Instruments
    • 4.3.1. Laboratory instruments market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.3.2. Incubators
      • 4.3.2.1. Incubators market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.3.3. Gram stainers
      • 4.3.3.1. Gram stainers market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.3.4. Bacterial colony counters
      • 4.3.4.1. Bacterial colony counters market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.3.5. Autoclave sterilizers
      • 4.3.5.1. Autoclave sterilizers market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.3.6. Petri dish fillers
      • 4.3.6.1. Petri dish fillers market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.4. Automated Culture
    • 4.4.1. Automated culture market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.4.2. Microbiology analyzers
      • 4.4.2.1. Microbiology analyzers market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.4.3. Molecular diagnostic instruments
      • 4.4.3.1. Molecular diagnostic instruments market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.4.4. Microscopes
      • 4.4.4.1. Microscopes market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.4.5. Mass spectrometers
      • 4.4.5.1. Mass spectrometers market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.5. Reagents
    • 4.5.1. Reagents market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 5. Clinical Microbiology: Disease Estimates & Trend Analysis

  • 5.1. Clinical Microbiology Market: Key Takeaways
  • 5.2. Clinical Microbiology Market: Movement & Market Share Analysis, 2022 & 2030
  • 5.3. Respiratory Diseases
    • 5.3.1. Respiratory diseases market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.4. Bloodstream Infections
    • 5.4.1. Bloodstream infections market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.5. Gastrointestinal Diseases
    • 5.5.1. Gastrointestinal diseases market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.6. Sexually Transmitted Diseases
    • 5.6.1. Sexually transmitted diseases market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.7. Urinary Tract Infections
    • 5.7.1. Urinary tract infections market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.8. Periodontal Diseases
    • 5.8.1. Periodontal diseases market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.9. Other Diseases
    • 5.9.1. Other diseases market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 6. Clinical Microbiology Market: Regional Estimates & Trend Analysis

  • 6.1. Regional Outlook
  • 6.2. Clinical Microbiology Market by Region: Key Takeaways
  • 6.3. North America
    • 6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.3.2. U.S.
      • 6.3.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.3.3. Canada
      • 6.3.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.4. Europe
    • 6.4.1. UK
      • 6.4.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.2. Germany
      • 6.4.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.3. France
      • 6.4.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.4. Italy
      • 6.4.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.5. Spain
      • 6.4.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.6. Denmark
      • 6.4.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.7. Sweden
      • 6.4.7.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.8. Norway
      • 6.4.8.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.5. Asia Pacific
    • 6.5.1. Japan
      • 6.5.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.2. China
      • 6.5.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.3. India
      • 6.5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.4. Australia
      • 6.5.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.5. Thailand
      • 6.5.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.6. South Korea
      • 6.5.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.6. Latin America
    • 6.6.1. Brazil
      • 6.6.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.6.2. Mexico
      • 6.6.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.6.3. Argentina
      • 6.6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.7. MEA
    • 6.7.1. South Africa
      • 6.7.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.7.2. Saudi Arabia
      • 6.7.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.7.3. UAE
      • 6.7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.7.4. Kuwait
      • 6.7.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 7.2. Market Participant Categorization
    • 7.2.1. BIOMERIEUX
      • 7.2.1.1. Company overview
      • 7.2.1.2. Financial performance
      • 7.2.1.3. Product benchmarking
      • 7.2.1.4. Strategic initiatives
    • 7.2.2. Cepheid.
      • 7.2.2.1. Company overview
      • 7.2.2.2. Financial performance
      • 7.2.2.3. Product benchmarking
      • 7.2.2.4. Strategic initiatives
    • 7.2.3. Danaher Corporation
      • 7.2.3.1. Company overview
      • 7.2.3.2. Financial performance
      • 7.2.3.3. Product benchmarking
      • 7.2.3.4. Strategic initiatives
    • 7.2.4. Bruker Corporation
      • 7.2.4.1. Company overview
      • 7.2.4.2. Financial performance
      • 7.2.4.3. Product benchmarking
      • 7.2.4.4. Strategic initiatives
    • 7.2.5. BD
      • 7.2.5.1. Company overview
      • 7.2.5.2. Financial performance
      • 7.2.5.3. Product benchmarking
      • 7.2.5.4. Strategic initiatives
    • 7.2.6. Hologic, Inc.
      • 7.2.6.1. Company overview
      • 7.2.6.2. Financial performance
      • 7.2.6.3. Product benchmarking
      • 7.2.6.4. Strategic initiatives
    • 7.2.7. F. Hoffmann-La Roche Ltd
      • 7.2.7.1. Company overview
      • 7.2.7.2. Financial performance
      • 7.2.7.3. Product benchmarking
      • 7.2.7.4. Strategic initiatives
    • 7.2.8. Alere, Inc.
      • 7.2.8.1. Company overview
      • 7.2.8.2. Financial performance
      • 7.2.8.3. Product benchmarking
      • 7.2.8.4. Strategic initiatives
Show more
Product Code: GVR-1-68038-142-9

List of Tables

  • Table 1 List of Abbreviation
  • Table 2 North America clinical microbiology market, by product, 2018 - 2030 (USD Million)
  • Table 3 North America clinical microbiology market, by disease, 2018 - 2030 (USD Million)
  • Table 4 North America clinical microbiology market, by region, 2018 - 2030 (USD Million)
  • Table 5 U.S. clinical microbiology market, by product, 2018 - 2030 (USD Million)
  • Table 6 U.S. clinical microbiology market, by disease, 2018 - 2030 (USD Million)
  • Table 7 Canada clinical microbiology market, by product, 2018 - 2030 (USD Million)
  • Table 8 Canada clinical microbiology market, by disease, 2018 - 2030 (USD Million)
  • Table 9 Europe clinical microbiology market, by product, 2018 - 2030 (USD Million)
  • Table 10 Europe clinical microbiology market, by disease, 2018 - 2030 (USD Million)
  • Table 11 Europe clinical microbiology market, by region, 2018 - 2030 (USD Million)
  • Table 12 Germany clinical microbiology market, by product, 2018 - 2030 (USD Million)
  • Table 13 Germany clinical microbiology market, by disease, 2018 - 2030 (USD Million)
  • Table 14 UK clinical microbiology market, by product, 2018 - 2030 (USD Million)
  • Table 15 UK clinical microbiology market, by disease, 2018 - 2030 (USD Million)
  • Table 16 France clinical microbiology market, by product, 2018 - 2030 (USD Million)
  • Table 17 France clinical microbiology market, by disease, 2018 - 2030 (USD Million)
  • Table 18 Italy clinical microbiology market, by product, 2018 - 2030 (USD Million)
  • Table 19 Italy clinical microbiology market, by disease, 2018 - 2030 (USD Million)
  • Table 20 Spain clinical microbiology market, by product, 2018 - 2030 (USD Million)
  • Table 21 Spain clinical microbiology market, by disease, 2018 - 2030 (USD Million)
  • Table 22 Denmark clinical microbiology market, by product, 2018 - 2030 (USD Million)
  • Table 23 Denmark clinical microbiology market, by disease, 2018 - 2030 (USD Million)
  • Table 24 Sweden clinical microbiology market, by product, 2018 - 2030 (USD Million)
  • Table 25 Sweden clinical microbiology market, by disease, 2018 - 2030 (USD Million)
  • Table 26 Norway clinical microbiology market, by product, 2018 - 2030 (USD Million)
  • Table 27 Norway clinical microbiology market, by disease, 2018 - 2030 (USD Million)
  • Table 28 Asia Pacific clinical microbiology market, by product, 2018 - 2030 (USD Million)
  • Table 29 Asia Pacific clinical microbiology market, by disease, 2018 - 2030 (USD Million)
  • Table 30 Asia Pacific clinical microbiology market, by region, 2018 - 2030 (USD Million)
  • Table 31 Japan clinical microbiology market, by product, 2018 - 2030 (USD Million)
  • Table 32 Japan clinical microbiology market, by disease, 2018 - 2030 (USD Million)
  • Table 33 China clinical microbiology market, by product, 2018 - 2030 (USD Million)
  • Table 34 China clinical microbiology market, by disease, 2018 - 2030 (USD Million)
  • Table 35 India clinical microbiology market, by product, 2018 - 2030 (USD Million)
  • Table 36 India clinical microbiology market, by disease, 2018 - 2030 (USD Million)
  • Table 37 Australia clinical microbiology market, by product, 2018 - 2030 (USD Million)
  • Table 38 Australia clinical microbiology market, by disease, 2018 - 2030 (USD Million)
  • Table 39 Thailand clinical microbiology market, by product, 2018 - 2030 (USD Million)
  • Table 40 Thailand clinical microbiology market, by disease, 2018 - 2030 (USD Million)
  • Table 41 South Korea clinical microbiology market, by product, 2018 - 2030 (USD Million)
  • Table 42 South Korea clinical microbiology market, by disease, 2018 - 2030 (USD Million)
  • Table 43 Latin America clinical microbiology market, by product, 2018 - 2030 (USD Million)
  • Table 44 Latin America clinical microbiology market, by disease, 2018 - 2030 (USD Million)
  • Table 45 Latin America clinical microbiology market, by region, 2018 - 2030 (USD Million)
  • Table 46 Brazil clinical microbiology market, by product, 2018 - 2030 (USD Million)
  • Table 47 Brazil clinical microbiology market, by disease, 2018 - 2030 (USD Million)
  • Table 48 Mexico clinical microbiology market, by product, 2018 - 2030 (USD Million)
  • Table 49 Mexico clinical microbiology market, by disease, 2018 - 2030 (USD Million)
  • Table 50 Argentina clinical microbiology market, by product, 2018 - 2030 (USD Million)
  • Table 51 Argentina clinical microbiology market, by disease, 2018 - 2030 (USD Million)
  • Table 52 Middle East and Africa clinical microbiology market, by product, 2018 - 2030 (USD Million)
  • Table 53 Middle East and Africa clinical microbiology market, by disease, 2018 - 2030 (USD Million)
  • Table 54 Middle East and Africa clinical microbiology market, by region, 2018 - 2030 (USD Million)
  • Table 55 South Africa clinical microbiology market, by product, 2018 - 2030 (USD Million)
  • Table 56 South Africa clinical microbiology market, by disease, 2018 - 2030 (USD Million)
  • Table 57 Saudi Arabia clinical microbiology market, by product, 2018 - 2030 (USD Million)
  • Table 58 Saudi Arabia clinical microbiology market, by disease, 2018 - 2030 (USD Million)
  • Table 59 UAE clinical microbiology market, by product, 2018 - 2030 (USD Million)
  • Table 60 UAE clinical microbiology market, by disease, 2018 - 2030 (USD Million)
  • Table 61 Kuwait clinical microbiology market, by product, 2018 - 2030 (USD Million)
  • Table 62 Kuwait clinical microbiology market, by disease, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Clinical Microbiology: Market outlook
  • Fig. 9 Clinical Microbiology: Competitive insights
  • Fig. 10 Parent market outlook
  • Fig. 11 Related/ancillary market outlook
  • Fig. 12 Penetration and growth prospect mapping
  • Fig. 13 Industry value chain analysis
  • Fig. 14 Clinical microbiology market driver impact
  • Fig. 15 Clinical microbiology market restraint impact
  • Fig. 16 Clinical microbiology market strategic initiatives analysis
  • Fig. 17 Clinical microbiology market: Product movement analysis
  • Fig. 18 Clinical microbiology market: product outlook and key takeaways
  • Fig. 19 Laboratory instruments market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 20 Incubators market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 21 Gram stainers market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 22 Bacterial colony counters market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 23 Autoclave sterilizers market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 24 Petri dish fillers market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 25 Automated culture systems market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 26 Microbiology analyzers market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 27 Molecular diagnostic instruments market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 28 Microscopes market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 29 Mass spectrometers market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 30 Reagents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 31 Clinical microbiology market: Disease movement analysis
  • Fig. 32 Clinical microbiology market: disease outlook and key takeaways
  • Fig. 33 Respiratory diseases market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 34 Bloodstream infections market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 35 Gastrointestinal diseases market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 36 Sexually transmitted diseases market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 37 Urinary tract infections market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 38 Periodontal diseases market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 Other diseases market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 Global clinical microbiology market: Regional movement analysis
  • Fig. 41 Global clinical microbiology market: Regional outlook and key takeaways
  • Fig. 42 North America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 43 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 46 UK market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 France market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 55 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 56 China market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 57 India market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 58 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 59 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 60 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 61 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 62 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 63 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 64 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 65 Middle East and Africa. market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 66 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 67 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 68 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 69 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)
Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!